Clinical Trial Update: Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass Procedures [Phase 3]

View source ↗

Summary

Phase 3 trial update from Anesiva, Inc. reports the completion of a study evaluating prevention of autogenous vein graft failure in coronary artery bypass proce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Anesiva, Inc. | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED